H-1B Wage Lookup

Data through FY2026 Q3 (Jun 30, 2026)

Astellas Gene Therapies, Inc.

Company profile for Astellas Gene Therapies, Inc. covers 3 filings across the reporting window. FY2026 certified median offer: $142,251.

FY2026 certified median
$142,251
Total filings
3
FY2026 25th–75th percentile
$142,251–$142,251
Top job title
Lead Biopharma Manufacturing Operations SFD-TC
Certified offers by fiscal year
Fiscal yearFilingsMedian25th percentile75th percentile
FY20241$101,816$101,816$101,816
FY20251$143,567$143,567$143,567
FY2026 (Q1–Q3)1$142,251$142,251$142,251

FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.

Median offer by fiscal year

Certified median offer, Astellas Gene Therapies, Inc.FY2024 $101,816; FY2025 $143,567; FY2026 (Q1–Q3) $142,251$0$50,000$100,000$150,000FY2024$101,816FY2025$143,567FY2026 (Q1–Q3)$142,251Certified median offer, Astellas Gene Therapies, Inc.FY2024 $101,816; FY2025 $143,567; FY2026 (Q1–Q3) $142,251$0$50k$100k$150kFY2024$101,816FY2025$143,567FY2026*$142,251
Certified H-1B LCAs, $15k–$2M, DOL OFLC

Top titles

  1. Lead Biopharma Manufacturing Operations SFD-TC1 filings
  2. Scientist II, Bioanalytics1 filings
  3. Senior Research Associate, Bioanalytics1 filings

Top cities

  1. South San Francisco2 filings
  2. Sanford1 filings

Employer and title details